Pegylated Interferon and Ribavirin
Sponsors
State University of New York - Upstate Medical University, Ortho Biotech Products, L.P., Hospital Clinic of Barcelona, Pacific Health Foundation, GlobeImmune
Conditions
AlcoholismAnemiaAsian AmericansChronic Hepatitis CChronic Hepatitis C InfectionDrug AbuseGenotype 1 Chronic Hepatitis CHIV
Phase 2
NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection
CompletedNCT00315432
Start: 2000-09-30End: 2003-11-30Updated: 2011-05-19
A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV)
CompletedNCT00328549
Start: 2001-10-31End: 2002-12-31Updated: 2011-05-19
Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection
CompletedNCT00606086
Start: 2007-12-31End: 2012-11-30Updated: 2014-06-27
Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients
CompletedNCT01055821
Start: 2010-05-31End: 2013-08-31Updated: 2013-08-13
Phase 4
Improving Hepatitis C Treatment in Injection Drug Users
CompletedNCT00148031
Start: 2003-09-30End: 2007-03-31Updated: 2013-04-24
Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.
CompletedNCT00383864
Start: 2001-07-31End: 2006-03-31Target: 55Updated: 2006-10-06
Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9
CompletedNCT00575224
Start: 2004-10-31End: 2009-09-30Updated: 2009-11-25
Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy
CompletedNCT01120795
Start: 2004-02-29End: 2006-07-31Updated: 2024-01-30